Exjade
Active Ingredient(s): DeferasiroxFDA Approved: * November 2, 2005
Pharm Company: * NOVARTIS
Category: Iron Chelator
Deferasirox, sold under the brand name Exjade & Asunra (in injectable form) & Oleptiss (Tablet formulation) both by Novartis among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[2][3] It is the first oral medication approved in the United States for this purpose.[4] It was appro... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.4 Discussions
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
Exjade and diarrhea
I have been taking Exjade at a daily rate of 2250 mg. I also have blood transfusions every two weeks. Of late I get chro...
1 REPLYexjade j code
What code could be used for Exjade if billed to a major medical plan?...